Search

Search Results

• Overcoming methotrexate induced liver toxicity: a role of triterpenoids

  B.A. Frolov, O.V. Kalinina, A.V. Kirillova, A.A. Shtil

  1-11

  01.07.2025

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed Mantle Cell Lymphoma Involving CNS: Two Case Reports and Literature Review

  Evgenii Olegovich Kunevich, N.N. Nemstsveridze, M.A. Mikhaleva, A.Yu. Kuvshinov, T.V. Ovchinnikova, E.V. Koryakina, S.V. Samarina, K.Yu. Krutikova, S.V. Sidorkevich, S.V. Voloshin

  184-196

  01.04.2025

• The Therapeutic Effect of Antitumor Drugs Erufosine and Doxorubicin on the Metastatic Process in the Testes of Hamsters with Graffi Myeloid Tumor. Morphometric and Histological Studies

  Iliana Najdenova Ilieva, I.V. Sainova, R.A. Toshkova, A.K. Georgieva, V.N. Nanev, R.D. Tzoneva

  18-26

  17.05.2024

• The Role of Polymorphic Variants of Р450 Cytochrome Genes as well as Genes GSTP1 and MDR1 in Toxic Complications of Program Drug Chemotherapy for Classical Hodgkin Lymphoma

  Yana Yurevna Shebunyaeva

  141-153

  01.04.2024

• Supportive Therapy in Multiple Myeloma: Practical Recommendations

  Maksim Valerevich Solovev, M.V. Soloveva, L.P. Mendeleeva

  426-448

  28.09.2023

• Cardiovascular Complications of the Immunotherapy of Hematological Malignancies: A Literature Review

  Geliya Rifkatovna Gimatdinova, O.E. Danilova, V.P. Kuzmin, G.I. Davydkin, Yu.V. Kostalanova, D.A. Kudlai, I.L. Davydkin

  407-412

  28.09.2023

• Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  229-241

  09.06.2023

• KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

  Elena Vital’evna Kuzmich, I.E. Pavlova, L.N. Bubnova, S.S. Bessmeltsev

  119-127

  03.03.2023

• Cardio-oncology and Oncohematology: Examination Algorithms, Prophylactic and Treatment of Cardiotoxicity, Trends in Rehabilitation

  Elena Ivanovna Emelina, G.E. Gendlin, I.G. Nikitin

  239-261

  01.04.2021

• Stable Chronology of Granulopoiesis under R(G)-DHAP Immunochemotherapy-Induced Cytotoxic Stress in Non-Hodgkin’s Lymphomas

  Kseniya Andreevna Sychevskaya, S.K. Kravchenko, F.E. Babaeva, A.E. Misyurina, A.M. Kremenetskaya, A.I. Vorob’ev

  204-219

  01.04.2021

• Hodgkin’s Lymphoma in HIV-Infected Patients

  Aleksandr Vasilevich Pivnik, A.M. Vukovich, N.V. Kremneva, M.G. Dubnitskaya, A.V. Tsakhilova

  63-68

  01.01.2021

• CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Kseniya Aleksandrovna Levchuk, E.V. Belotserkovskaya, D.Yu. Pozdnyakov, L.L. Girshova, A.Yu. Zaritskey, A.V. Petukhov

  138-148

  01.01.2021

• Bendamustine in the Treatment of Relapsed/Refractory Hodgkin’s Lymphoma: Literature Review and Clinical Experience

  Stanislav Sergeevich Shklyaev, N.A. Falaleeva, T.I. Bogatyreva, A.Yu. Terekhova, M.A. Danilova

  136-149

  01.04.2020

• Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

  Yuliya Eikhenovna Vinogradova, N.G. Chernova

  179-184

  01.04.2019

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Soluble Guanylyl Cyclase (sGC) in Mechanisms of Hypotensive and Antiaggregatory Effects Induced by Teraphtal (TP, sodium salt 4,5-cardoxyphtalocyanin-cobalt)

  Tat’yana Aleksandrovna Sidorova, N.V. Pyatakova, I.S. Severina, О.L. Kaliya, G.K. Gerasimova

  138-147

  01.04.2016

• Hodgkin’s lymphoma and male fertility disorders

  A.А. Vinokurov

  258-273

  01.07.2013